(Q46356736)

English

Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

0 references

Human herpesvirus 2

1 reference

based on heuristic

inferred from title

author name string

Sudha Bhavanam

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

Denis P Snider

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

Charu Kaushic

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

language of work or name

0 references

publication date

18 September 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

26

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

48

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

6165-6172

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

Herpes simplex virus type 2: epidemiology and management options in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Influence of ovarian hormones on urogenital infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Herpes Simplex: Insights on Pathogenesis and Possible Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Immunologic uniqueness of the genital tract: challenge for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Influence of the murine oestrous cycle on the induction of mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Effects of reproductive hormones on experimental vaginal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.08.045

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18804503

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46356736&oldid=2107582319"